health economics and outcomes research

Research in Review

PD-1 Inhibitor Improves Response Rates, Survival Times in Certain Patients With NSCLC

06/23/2017

JCP Editors

A programmed death 1 (PD-1) inhibitor is associated with similar efficacy to chemotherapy in patients with non-small cell lung cancer (NSCLC), but improves response rates and survival times in subgroups of patients,...

A...

06/23/2017

Journal of Clinical Pathways

Research in Review

DLBCL Survival Outcomes Improved With Combination Therapy

06/22/2017

JCP Editors

Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...

...

06/22/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Examines Treatment Options for Type of Colorectal Cancer

06/22/2017

JCP Editors

A recent study compared the effects of first-line chemotherapy with two different drugs in patients with advanced or metastatic colorectal cancer, published in JAMA (2017;317[23]:2392-2401). ----- Related...

A...

06/22/2017

Journal of Clinical Pathways

Research in Review

Embedding Palliative Care in Treatment Clinics Improves Access to Care

06/21/2017

JCP Editors

An embedded palliative care program results in earlier and prolonged access to palliative care, according to research published in the Journal of Oncology Practice (published online June 2017;...

An...

06/21/2017

Journal of Clinical Pathways

Research in Review

Higher Dose Does Not Improve Efficacy of Gastric Cancer Treatment

06/20/2017

JCP Editors

A higher dose treatment for a type of metastatic gastric adenocarcinoma showed equivalent efficacy and safety, according to research published in the Journal of Clinical Oncology (published online June 2017;...

A...

06/20/2017

Journal of Clinical Pathways

Research in Review

ED Visits Prevented Through Improved Cancer Symptom Management and Outpatient Care

06/15/2017

JCP Editors

Better symptom management and readily available outpatient care for patients with cancer can reduce emergency department (ED) visits that do not require admission by as much as 53%, according to a recent...

Better...

06/15/2017

Journal of Clinical Pathways

Research in Review

Reducing Cancer Drug Waste May Lead to Significant Cost Savings

06/13/2017

JCP Editors

Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...

...

06/13/2017

Journal of Clinical Pathways

Research in Review

Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing

05/31/2017

JCP Editors

Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...

Women...

05/31/2017

Journal of Clinical Pathways

Research Reports

Cost-Effectiveness of a Patient Navigation Program for Colorectal Cancer Screening

05/12/2017

Whitney C Rhodes, PhD, MSPA

Yvonne Kellar-Guenther, PhD

Arnold H Levinson, PhD, MJ

Andrea Dwyer, BS

R Mark Gritz, PhD

Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...

...

05/12/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness of Early-Stage Breast Cancer Treatment Options Vary Significantly

04/21/2017

JCP Editors

Certain therapy options for early-stage breast cancer have fewer associated complications and are much less expensive than others, according to a study published in the Journal of the National Cancer Institute...

...

04/21/2017

Journal of Clinical Pathways